BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15144895)

  • 1. A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2.
    Sasaoka R; Terai H; Toyoda H; Imai Y; Sugama R; Takaoka K
    Biochem Biophys Res Commun; 2004 Jun; 318(3):704-9. PubMed ID: 15144895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist.
    Toyoda H; Terai H; Sasaoka R; Oda K; Takaoka K
    Bone; 2005 Oct; 37(4):555-62. PubMed ID: 16027058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of recombinant human bone morphogenetic protein-2 (rhBMP-2)-induced new bone formation by concurrent treatment with parathyroid hormone and a phosphodiesterase inhibitor, pentoxifylline.
    Horiuchi H; Saito N; Kinoshita T; Wakabayashi S; Tsutsumimoto T; Otsuru S; Takaoka K
    J Bone Miner Metab; 2004; 22(4):329-34. PubMed ID: 15221490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading.
    Hagino H; Kuraoka M; Kameyama Y; Okano T; Teshima R
    Bone; 2005 Mar; 36(3):444-53. PubMed ID: 15777678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro.
    Takayama K; Suzuki A; Manaka T; Taguchi S; Hashimoto Y; Imai Y; Wakitani S; Takaoka K
    J Bone Miner Metab; 2009; 27(4):402-11. PubMed ID: 19252814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effects of a prostaglandin EP4 receptor agonist on recombinant human bone morphogenetic protein-2 mediated spine fusion in a rabbit model.
    Namikawa T; Terai H; Hoshino M; Kato M; Toyoda H; Yano K; Nakamura H; Takaoka K
    Spine (Phila Pa 1976); 2007 Oct; 32(21):2294-9. PubMed ID: 17906568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phosphodiesterase inhibitor-4, rolipram, on new bone formations by recombinant human bone morphogenetic protein-2.
    Horiuchi H; Saito N; Kinoshita T; Wakabayashi S; Yotsumoto N; Takaoka K
    Bone; 2002 Apr; 30(4):589-93. PubMed ID: 11934650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier dependent cell differentiation of bone morphogenetic protein-2 induced osteogenesis and chondrogenesis during the early implantation stage in rats.
    Takita H; Vehof JW; Jansen JA; Yamamoto M; Tabata Y; Tamura M; Kuboki Y
    J Biomed Mater Res A; 2004 Oct; 71(1):181-9. PubMed ID: 15368268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human fibroblast growth factor-2 on intramuscular ectopic osteoinduction by recombinant human bone morphogenetic protein-2 in rats.
    Kakudo N; Kusumoto K; Kuro A; Ogawa Y
    Wound Repair Regen; 2006; 14(3):336-42. PubMed ID: 16808813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic bone formation after implantation of a slow release system of polylactic acid and rhBMP-2.
    Gruber R; Weich HA; Dullin C; Schliephake H
    Clin Oral Implants Res; 2009 Jan; 20(1):24-30. PubMed ID: 19126104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers.
    Kim CS; Kim JI; Kim J; Choi SH; Chai JK; Kim CK; Cho KS
    Biomaterials; 2005 May; 26(15):2501-7. PubMed ID: 15585252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice.
    Turgeman G; Zilberman Y; Zhou S; Kelly P; Moutsatsos IK; Kharode YP; Borella LE; Bex FJ; Komm BS; Bodine PV; Gazit D
    J Cell Biochem; 2002; 86(3):461-74. PubMed ID: 12210753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the osteoinductivity of bioimplants containing recombinant human bone morphogenetic proteins 2 (Infuse) and 7 (OP-1).
    Barr T; McNamara AJ; Sándor GK; Clokie CM; Peel SA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):531-40. PubMed ID: 20188607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic bone formation in mice associated with a lactic acid/dioxanone/ethylene glycol copolymer-tricalcium phosphate composite with added recombinant human bone morphogenetic protein-2.
    Kato M; Namikawa T; Terai H; Hoshino M; Miyamoto S; Takaoka K
    Biomaterials; 2006 Jul; 27(21):3927-33. PubMed ID: 16564087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation.
    Sintuu C; Murray SS; Behnam K; Simon R; Jawien J; Silva JD; Duarte ME; Brochmann EJ
    J Orthop Res; 2008 Jun; 26(6):753-8. PubMed ID: 18253966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2).
    Kato M; Toyoda H; Namikawa T; Hoshino M; Terai H; Miyamoto S; Takaoka K
    Biomaterials; 2006 Mar; 27(9):2035-41. PubMed ID: 16256191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation.
    Tokuhara Y; Wakitani S; Imai Y; Nomura C; Hoshino M; Yano K; Taguchi S; Kim M; Kadoya Y; Takaoka K
    J Bone Miner Metab; 2010; 28(1):17-24. PubMed ID: 19554392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prefabricated muscle flap including bone induced by recombinant human bone morphogenetic protein-2: an experimental study of ectopic osteoinduction in a rat latissimus dorsi muscle flap.
    Kusumoto K; Bessho K; Fujimura K; Akioka J; Ogawa Y; Iizuka T
    Br J Plast Surg; 1998 Jun; 51(4):275-80. PubMed ID: 9771344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of bone morphogenetic protein-2-induced new bone formation in mice by the phosphodiesterase inhibitor pentoxifylline.
    Horiuchi H; Saito N; Kinoshita T; Wakabayashi S; Tsutsumimoto T; Takaoka K
    Bone; 2001 Mar; 28(3):290-4. PubMed ID: 11248659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
    Nakagawa K; Imai Y; Ohta Y; Takaoka K
    Bone; 2007 Oct; 41(4):543-8. PubMed ID: 17681894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.